Effect of topical versus oral simvastatin as adjuvant therapy for treatment of patients with acne vulgaris
Phase 2
- Conditions
- Acne vulgaris.Acne vulgaris
- Registration Number
- IRCT201612049014N135
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 69
Inclusion Criteria
age of 18 to 65 years; moderate to severe acne vulgaris based on GAGS criteria for 6 months.
Exclusion criteria: pregnancy; breastfeeding; liver disorder; renal disorder; using drug for acne during the last month.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical sign of acne vulgaris. Timepoint: before and 8 weeks after treatment. Method of measurement: using GAGS criteria.
- Secondary Outcome Measures
Name Time Method